- Type de poste: PhD/Doctorat
- Secteur : Public
- Localité : International
- Limite de candidature : 03/12/2021
- Profil de poste:
Recherche et innovation
- Domaine(s) :
Microbiologie et Immunologie, Autre
The bacterium Streptomyces davaonensis produces the antibiotic roseoflavin in the stationary phase of growth. Roseoflavin is a structural riboflavin (vitamin B2) analog and acts as an antimetabolite. The Mack group was able to show that roseoflavin negatively affects FMN riboswitches as well as flavoproteins and thus the antibiotic has multiple cellular targets.
The Mack group also has elucidated the biosynthetic pathway of roseoflavin. One important open question is at present how roseoflavin is exported from the producer cell. Our preliminary experiments clearly show that a yet unknown transporter is responsible for roseoflavin export as roseoflavin is found in the supernatant of cultures of the producer cell. Such an exporter protein must be highly specific to avoid export of essential riboflavin. Export of roseoflavin is important for the producer, otherwise the compound would not be able to inhibit growth of competing microorganisms in a natural environment.
The objective of the present project is the identification of the roseoflavin exporter in S. davaonensis. Five different work packages describe experiments which should lead to the identification of the roseoflavin exporter. It is unclear at present whether a single protein or whether multiple proteins form this unique exporter.
We plan to carry out systematic deletion experiments and co-expression experiments in different bacterial backgrounds to identify the roseoflavin exporter. In case these experiments fail we plan to carry out protein-protein interaction experiments (proximity‐dependent biotin identification “BioID”, cooperation with Oliver Valerius, Göttingen).
The hypothesis thereby is that the last enzyme of roseoflavin biosynthesis, RosA, which binds its reaction product roseoflavin very tightly, interacts with a membrane bound exporter. It is also possible that RosA interacts with a binding protein which then brings roseoflavin to the elusive exporter.
Employing BioID partners of RosA can be identified. In principle uptake systems – especially for riboflavin – are well described in bacteria. In contrast, only very few exporters are known which makes the present project especially interesting.
Please submit your application exclusively through the HBIGS application system:
Please read more under “Open PhD Positions” on: http://www.hbigs.uni-heidelberg.de
Web site for additional job details: http://www.hbigs.uni-heidelberg.de
The successful candidate has exprerience in the following fields:
Microbiology, Bacteria, antibiotics, vitamins, Streptomycetes, transporter proteins
A person interested in bacterial membrane bound transporters (importers/exporters) in general would be the most appropriate.
Moreover, since we also will use a genetic approach to identify the novel elusive roseoflavin exporter, the candidate also should be familiar with state-of-the-art cloning techniques.
We will teach you to use a bacterial CRISPR-Cas9 system and BioID.